newsfilter
← Latest News
Business Wire·

Aptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company will host a conference